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1248Objective: Our goal was to determine if a clinical outcome score derived from early postoperative events is as-
sociated with 18- to 24-month Psychomotor Developmental Index (PDI) score among infants undergoing car-
diopulmonary bypass surgery.
Methods: We included infants aged 6 weeks who underwent surgery during 2002-2006, all of whom were
referred for neurodevelopmental evaluation at age 18 to 24 months. We excluded children with chromosomal
abnormalities, hearing loss, cerebral palsy, or a Bayley III assessment. The prespecified clinical outcome score
had a range of 0 to 7. Lower scores indicated a more rapid postoperative recovery. Patients requiring
extracorporeal membrane oxygenation were assigned a score of 7.
Results: Ninety-nine subjects were included. Surgical procedures were arterial switch (n ¼ 36), Norwood
(n ¼ 26), repair of total anomalous pulmonary venous connection (n ¼ 16), and other (n ¼ 21). Four subjects
had postoperative extracorporeal membrane oxygenation. Clinical outcome scores were highest in the Norwood
group (mean 4.1  1.4) compared with the arterial switch group (1.9  1.6) (P<.001), total anomalous pul-
monary venous connection group (1.6  2.0) (P<.001), and other group (3.3  1.6, P ¼ not significant). A
mean decrease in PDI of 10.9 points (95% confidence interval, 4.9-16.9; P ¼ .0005) was observed among chil-
dren who had a clinical outcome score 3, compared with those with a clinical outcome score<3. Time until
lactate 2.0 mmol/L increased with increasing clinical outcome score (P ¼ .0003), as did highest 24-hour ino-
trope score (P<.0001).
Conclusions: Clinical outcome scores of 3 were associated with a significantly lower PDI at age 18 to
24 months. This score may be valuable as an end point when evaluating novel potential therapies for this
high-risk population. (J Thorac Cardiovasc Surg 2013;145:1248-54)Earn CME credits at
http://cme.ctsnetjournals.orgSupplemental material is available online.
Mortality from congenital heart disease has decreased sig-
nificantly during the past 3 decades.1,2 This is particularly
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However, neurodevelopmental outcomes are difficult to
predict in early childhood, and interventions in infancy
that may affect neurodevelopment are challenging to evalu-
ate given a time lag between intervention and neurodeve-
lopmental assessment that may be 2 years or longer.
Many innovative therapies for infants undergoing cardio-
pulmonary bypass (CPB) surgery have been evaluated in re-
cent years and will continue to evolve, yet selection of
primary end points for clinical trials remains challenging.
These issues speak to the potential value of surrogate out-
comes that reliably predict neurodevelopmental sequelae
and can be measured early in the postoperative course.
In pediatric patients undergoing cardiac surgery, several
scoring systems have been developed that predict mortal-
ity.3,4 However, correlation with neurodevelopmental
outcomes has not been a focus of publications to date.
Mackie and colleagues5 developed a composite clinical
outcome score for neonates undergoing complex aortic
arch reconstruction that discriminated patients receiving in-
travenous postoperative tri-iodothyronine from those re-
ceiving placebo. This score is objective and measurable in
intensive care units (ICUs) at no cost. Possible scores range
from 0 (reflecting least morbidity) to 7 (reflecting death or
use of postoperative mechanical circulatory support).gery c May 2013
Abbreviations and Acronyms
CPB ¼ cardiopulmonary bypass
ICU ¼ intensive care unit
PDI ¼ Psychomotor Developmental Index
LOS ¼ length of stay
BSID-II ¼ Bayley Scales of Infant Development,
2nd edition
MDI ¼ Mental Developmental Index
TAPVC ¼ total anomalous pulmonary venous
connection
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DHowever, the full range of potential scores was not observed
among patients in that initial validation study.5 Therefore,
a modification of this score was developed. The objective
of our study was to examine the performance of this modi-
fied score. We hypothesized that the modified clinical
outcome score would correlate with Psychomotor Develop-
mental Index (PDI) score at age 18 to 24 months. A second-
ary objective of this study was to determine the correlation
between this modified clinical outcome score and other im-
portant perioperative events, namely time to normalization
of postoperative lactate, postoperative inotrope score, post-
operative ICU length of stay (LOS), and total hospital LOS.METHODS
Design
This study is part of a larger multiprovince inception cohort that was
established to evaluate neurodevelopmental outcomes of infants aged
6 weeks who undergo cardiopulmonary bypass surgery in western Canada.6
This inception cohort prospectively collected preoperative, intraoperative,
and postoperative variables, as previously described.7
Subjects
Inclusion criteria were infants 6 weeks of age who underwent cardio-
pulmonary bypass surgery at the Stollery Children’s Hospital in Edmonton,
Alberta, Canada, between January 2002 and February 2006, all of whom
received multidisciplinary neurodevelopmental assessments including the
Bayley Scales of Infant Development (BSID-II)8 through a developmental
clinic with the exception of 1 child who was lost to follow-up. Develop-
mental clinics were located in Edmonton and Calgary, Alberta; Regina
and Saskatoon, Saskatchewan; Vancouver, British Columbia; and Winni-
peg, Manitoba, Canada. We excluded children with known chromosomal
abnormalities (eg, Trisomy 21 or deletion 22q11.2), cerebral palsy, or mod-
erate to severe hearing loss, and those who had a Bayley III assessment
rather than a BSID-II, because the two are not equivalent.9 The inception
cohort follow-up had ethics board approvals from each site. All parents/
guardians provided written informed consent. The Health Research Ethics
Board at the University of Alberta approved the study.
Early Childhood Assessments
Children were evaluated at age 18 to 24 months. Certified pediatric psy-
chologists and psychometrists administered the BSID-II,8 yielding separate
Mental Developmental Index (MDI) and PDI standardized scores. The
MDI assesses memory, problem solving, number concepts, vocalization,
language, and social skills. The PDI assesses gross motor and fine motor
skills. The mean score for both the MDI and PDI is 100 15. PediatriciansThe Journal of Thoracic and Carexperienced in neurodevelopmental assessment examined each child for
evidence of cerebral palsy or visual impairment, defined as corrected visual
acuity in the better eye of<20/60. Hearing was evaluated by experienced
certified pediatric audiologists in soundproof environments as has been de-
scribed.6 Hearing loss was defined as binaural sensorineural hearing loss of
more than 40 dB at any frequency from 250 to 4000Hz.Maternal education
was determined by years of schooling.
Clinical Outcome Score
The original clinical outcome score developed by Mackie and col-
leagues5 is shown in Table 1. The components of the clinical outcomes
score were derived with the intent of using variables that could be recorded
objectively and early in the postoperative course, that are clinically mean-
ingful (eg, time to first extubation) and that reflect hemodynamic status. No
subjects in our study or the original publication had a score of 5 or 6. To
improve the distribution of subjects across the range of possible scores
(0 to 7), a modified clinical outcome score was developed (Table 1) using
the same variables as the previous score, but with a modified score weight-
ing. The score was calculated by adding the subscore of each individual
component (range, 0 to 2 each). Subjects requiring postoperative extracor-
poreal membrane oxygenation were assigned a score of 7, the highest pos-
sible score, to reflect the most severe morbidity.
Inotrope Score
The postoperative inotrope score was calculated as per Wernovsky and
colleagues.10 The highest 24-hour postoperative inotrope score for a given
patient was recorded for the purpose of correlation with the clinical out-
come score.
Lactate
Serum lactatewasmeasured postoperatively in the ICUwith a frequency
that was determined by the responsible intensivist. All blood gases ana-
lyzed in the ICU have a point of care lactate result, and are usually done
during the first postoperative day at least every 4 hours, as previously
described.11 The time interval between weaning from cardiopulmonary
bypass to first lactate 2.0 mmol/L was measured in hours.
Statistical Analysis
Categorical data are presented as proportions. Continuous data are
expressed as mean  standard deviation or median with interquartile
range. One-way analysis of variance with Tamhane’s multiple compari-
sons and Fisher exact test were used to compare surgical groups; Bonfer-
roni correction was applied. Descriptive variables for outcomes were
analyzed with Student t test, c2 test, and Fisher exact test. Correlations
between clinical outcome score and other outcome variables were exam-
ined using Spearman rank order correlation coefficient. Subjects with
a clinical outcome score of 6 or 7 were grouped together due to small
sample size in these groups. Exploratory data analyses supported the
use of multiple indicators for the clinical outcome score, with the lowest
score being the reference category. Multiple linear regression analysis in-
cluded clinical outcome score and any other potential predictor variables
having P<.10 on univariate linear regression analysis, and after checking
for multicolinearity. Potential predictor variables considered were birth
weight, gestational age at birth, age at surgery (in days), year of surgery,
number of preoperative days of ventilation, duration of cardiopulmonary
bypass, duration of deep hypothermic circulatory arrest, lowest flow rate
on cardiopulmonary bypass, palliative procedure (eg, Norwood) versus
complete biventricular repair, mother’s years of schooling, and antenatal
diagnosis (yes/no). All analyses were 2-sided. Statistical analyses were
performed using SPSS version 17 (2008; IBM Co, Armonk, NY) and
SAS version 9.1 (2007; SAS Institute, Cary, NC), and R version 2.30
(2009; Institute for Statistics and Mathematics, Vienna University,
Vienna, Austria).diovascular Surgery c Volume 145, Number 5 1249
TABLE 1. Clinical outcome score and modified clinical outcome score
Clinical variable
Clinical outcome score Modified clinical outcome score
0 1 2 0 1 2
Time until first negative fluid balance (d) 3 4-5 6 1 2 3
Time until sternal closure (d) 2 3-4 5 1 2-4 5
Time until first extubation (d) 4 5-8 9 4 5-8 9
Death or use of ECMO assigned score of 7
ECMO, Extracorporeal membrane oxygenation.
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DRESULTS
One hundred seventy-one infants met inclusion criteria.
Of these, 25 (14.6%) died, 19 were excluded (12 for chro-
mosomal abnormalities, 6 for sensorineural hearing loss, 1
for cerebral palsy), and 1 was lost to follow-up. Twenty-
seven had a Bayley III rather than BSID-II assessment.
The remaining 99 subjects were included in this analysis.
Surgical procedures performed were: arterial switch
(n ¼ 36), Norwood stage 1 (n ¼ 26), repair of total anoma-
lous pulmonary venous connection (TAPVC) (n ¼ 16), and
other (n¼ 21). The other group consisted of complete repair
of interrupted aortic arch (n ¼ 10), truncus arteriosus
(n ¼ 3), and tetralogy of Fallot (n ¼ 2); Blalock-Taussig
shunt for tetralogy of Fallot with atrioventricular septal de-
fect (n¼ 1); Blalock-Taussig shunt for atrioventricular sep-
tal defect and pulmonary atresia (n ¼ 1); Yasui procedure
for tunnel-like left ventricular outflow obstruction and ven-
tricular septal defect (n ¼ 1); pulmonary artery band and
atrial septectomy for double outlet right ventricle (n ¼ 1);
resection of a right ventricular mass (n ¼ 1); and tricuspid
valve repair with transannular right ventricular outflow
patch for Ebstein’s anomaly with pulmonary atresia (n¼ 1).
Preoperative, intraoperative, and postoperative variables
are provided in Table 2. The distribution of modified clinical
outcome scores among these 99 subjects is shown in Figure 1.
Four subjects had postoperative extracorporeal membrane
oxygenation and therefore were assigned a score of 7. Clini-
cal outcome scores were highest in the Norwood group with
a mean of 4.1 1.4 compared with the arterial switch group
with a mean of 1.9  1.6 (P<.001) and the TAPVC group
with amean of 1.6 2.0 (P<.001). Scores in the other group
were 3.3  1.6, not statistically significantly different from
the Norwood, arterial switch, or TAPVC groups.
All three components of the clinical outcome score
(Table 1) correlated with PDI on univariate analysis (data
not shown). On multiple regression analysis, PDI scores
were lower amongst patients with a clinical outcome score
3 (Table E1 and Figure 2). After adjusting for age at sur-
gery, a decrease in PDI score of 10.9 (95% confidence
interval 4.9-16.9) (P ¼ .0005) was found among subjects
with a clinical outcome score 3 compared with those
with a score<3. There was a marginally significant change
of 12.5 in the percent of variation (R2) in PDI scores
explained by the clinical outcome score when added to
a model consisting of age at surgery (P ¼ .051). There1250 The Journal of Thoracic and Cardiovascular Surwas a trend toward a lower MDI score of 5.8 (95% confi-
dence interval, 0.5 to 12.1) (P ¼ .068) among subjects
with a clinical outcome score 3 compared with those
with a score<3, after adjusting for age at surgery and years
of mother’s education (Table E2).
It was not possible to include ICU LOS, total hospital
LOS, or duration of preoperative ventilation in the multiple
regression analysis, because these variables were highly
correlated with the clinical outcome score. On univariate
analysis these variables all had a lesser effect on PDI as
did the clinical outcome score, reflecting an advantage of
the clinical outcome score over these variables. For exam-
ple, the percentage of variance in PDI score explained by
total hospital LOS was 21.3%. However, each additional
30 days in hospital was associated with a mean decrease
in PDI score of 6.6, compared with a mean decrease of
10.9 with clinical outcome scores of 3 or higher.
Longer time to first lactate2.0mmol/L and highest post-
operative inotrope score both had a positive correlation with
the clinical outcome score (P¼ .0003 andP<.0001, respec-
tively) (Figures 3 and 4). Postoperative length of ICU stay
also had a positive correlation with clinical outcome score
(P < .0001) (Figure E1), as did total hospital LOS (P
< .0001) (data not shown).
DISCUSSION
We found that a clinical outcome score derived from the
timing of postoperative events among infants aged
 6 weeks undergoing cardiopulmonary bypass surgery was
associated with PDI score at age, 18 to 24 months, time to
normalization of serum lactate, highest postoperative ino-
trope score, and with ICU and total hospital LOS. Clinical
outcome scores were higher among subjects undergoing
Norwood stage 1 palliation compared with those undergo-
ing the arterial switch procedure or repair of TAPVC. The
full range of potential scores was observed among the study
population. Subjects were equally divided among those
having low scores (0 to 2), reflecting a more rapid postoper-
ative recovery, and those having a high score (3 to 7),
reflecting greater postoperative morbidity.
PDI scores were significantly lower among subjects hav-
ing a clinical outcome score 3, compared with those with
a score <3. The relationship between clinical outcome
score and PDI was not linear, suggesting that there is
a threshold effect of perioperative hemodynamic status ongery c May 2013
TABLE 2. Preoperative, intraoperative, and postoperative variables by type of infant cardiac surgery
Variable Norwood (n ¼ 26) Arterial switch (n ¼ 36) TAPVC repair (n ¼ 16) Other (n ¼ 21)
Preoperative
Age at surgery (d) 10.3  8.8 12.3  8.2 17  15 18.4  15.2
Gestational age (wk) 39.6  1.2 38.9  1.3 39.3  1.6 39.1  1.4
Duration of preoperative ventilation (d) 8.2  8.7 5  4 2.5  4.5 5.1  7.9
Intraoperative
Duration of cardiopulmonary bypass (min) 130  52* 141  50* 61  28 121  50*
Duration of aortic cross-clamping (min) 40  13 67  23*,y 36  21 56  36*
Duration of DHCA (min) (n ¼ 62) 24.2  13.5 7.4  4.5*,y 27.1  6.9 39.2  26.3
Lowest flow (mL/kg/min) (for>10 min) 80.7  43.5 113.7  27.8 145.3  10.1 113  38.5
Postoperative
Time until lactate 2.0 mmol/L (h) 21.3  16.5 14.2  17.8 17.0  14.8 17.4  12.9
Highest 24-h inotrope score 21.5  9.9 14.1  8.5 14.6  12.9 17.5  14.9
Time until first negative fluid balance (d) 2.1  1.5 1.6  .6 1.6  .8 2.1  .5
Delayed sternal closure (n ¼ 52) 26 10 2 14
Time until sternal closure (d) 5.4  4.4 1.2  2.6y 1.1  2.6y 2.7  2.5
Time until first extubation (d) 11.7  5.6 7.4  6.4 5.8  4.0 8.6  4.3
Total duration of postoperative ventilationz (d) 15.6  15.8 8.4  6.5 7.9  6.2 11.2  8.9
Total hospital length of stayx (d) 52.4  55.6 23  13.6 17.9  11.4 27.7  16.7
Postoperative length of stay, ICU and ward (d) 44.3  54.7 17.2  11.9 15  9.7 22.3  17.3
Mother’s years of schooling 13.2  1.8 12.1  3.3 12.1  3.3 14.4  1.9
Age at neurodevelopmental testing (mo) 21.1  3.5 20.7  2.8 21.3  3.8 21.9  2.9
Mental Developmental Index 86.2  17.3 88.2  16.9 83.5  20.2 82.8  16.3
Psychomotor Developmental Index 77.5  18.6 90.6  11.3 85.2  12.5 82.5  17.1
Clinical outcome score 4.1  1.4* 1.9  1.6y 1.6  2.0 3.3  1.6
Results are presented as mean  standard deviation unless otherwise specified. DHCA, Deep hypothermic circulatory arrest; ICU, intensive care unit; TAPVC, total anomalous
pulmonary venous connection. *Difference from TAPVC at P<.001. yDifference from Norwood at P<.001. zFifteen patients required reintubation and therefore had a total
duration of postoperative ventilation that exceeded time until first extubation. xIncludes pre- and postoperative days.
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Dcerebral injury. It is not possible to conclude to what degree
congenital brain abnormalities or preoperative insults con-
tributed to lower PDI scores, relative to a difficult postop-
erative clinical course reflected by a high clinical
outcome score. Although the Bayley scales are not an intel-
ligence test, low scores do identify patients at risk for poor
neurodevelopmental outcomes.12-15 The relationship
between clinical outcome score with MDI did not reach0
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FIGURE 1. Distribution of modified clinical outcome scores among sub-
jects undergoing a single ventricle palliative procedure (n ¼ 29) (26 Nor-
wood, 2 Blalock-Taussig shunt, and 1 pulmonary artery band with atrial
septectomy) vs a biventricular repair (n ¼ 70).
The Journal of Thoracic and Carstatistical significance. This may have occurred because
MDI scores were less affected than PDI scores among the
Norwood group, a finding that has been observed by
others.6,16,17
Time until lactate 2.0 mmol/L and highest postopera-
tive inotrope score reflect early postoperative hemodynamic
status and correlated well with the clinical outcome score
(Figures 3 and 4). Serum lactate has been used as a marker40
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FIGURE 2. Relationship between mean Psychomotor Developmental In-
dex (PDI) score and clinical outcome score. Vertical bars represent 1 stan-
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FIGURE 3. Relationship between postoperative time to lactate 2.0
mmol/L and clinical outcome score (rho ¼ 0.36; P ¼ .0003).
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Dof adverse outcomes after pediatric cardiac surgery, includ-
ing increased ICU LOS18 and mortality.11,18-20 Trittenwein
and colleagues21 demonstrated a relationship between
higher lactate and cerebral damage after pediatric cardiac
surgery, and our group demonstrated the value of serial
postoperative lactate determination to help differentiate
those with intact versus adverse neurodevelopmental out-
come in a cross-sectional population after CPB surgery at
age, 6 weeks.11
Postoperative inotrope score has also been described as
a surrogate for morbidity in children undergoing CPB sur-
gery. Gaies and colleagues22 reported that a vasoactive-
inotropic score modified slightly from the inotrope score
originally described by Wernovsky and colleagues10 corre-
lated strongly with time to first negative fluid balance, time
to first extubation, and ICU LOS, and is consistent with our
finding that the clinical outcome score correlated with
highest 24-hour inotrope score. An association with neuro-
developmental outcome was not explored in the study
by Gaies and colleagues22 and the predictive value of0
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FIGURE 4. Relationship between highest postoperative inotrope score
and clinical outcome score (rho ¼ 0.61; P<.0001).
1252 The Journal of Thoracic and Cardiovascular Surinotrope scores relative to other postoperative parameters
is unknown.
The correlation between clinical outcome score and ICU
LOS (Figure E1) was anticipated given that the events de-
termining the clinical outcome score (Table 1) must occur
in the ICU rather than on the ward. However, the clinical
outcome score also correlated well with total postoperative
LOS (ICU and ward combined), which reflects the sum of
both early and late postoperative morbidity. This is relevant
as LOS correlates with neurodevelopmental outcomes
among children after CPB surgery.23 Newburger and col-
leagues23 reported that among 8-year old children who
had undergone the arterial switch operation in infancy,
both longer ICU LOS and longer hospital LOS were associ-
ated with lower full-scale intelligence quotient and verbal
intelligence quotient even after adjustment for perioperative
and sociodemographic variables. In our study we found that
each additional 30 days spent in the hospital was associated
with a mean decrease in PDI of 6.6 points. The clinical out-
come score, although its percent of variance (ie, R2) was
somewhat smaller than LOS, corresponded to a more dra-
matic drop in mean PDI of 10.9 for scores 3.
Clinical scoring systems have been previously evaluated
in children undergoing CPB surgery. Zobel and col-
leagues24 applied the Acute Physiologic Score for Children,
Pediatric Risk of Mortality, Therapeutic Intervention Scor-
ing System, and Organ System Failure score. All 4 scores
differed significantly between survivors and nonsurvi-
vors.24 However, that study was done during an earlier era
(ie, 1989 to 1992) and did not evaluate neurodevelopmental
outcomes. More recent studies have shown that the Risk
Adjustment for Congenital Heart Surgery category has
been validated as a risk factor for mortality in pediatric
cardiac surgery,3 as has the modified sequential organ
failure assessment score.4 The Aristotle Basic Complexity
score predicts infants aged <6 months having longer
ICU LOS.25 However, we are not aware of scoring systems
that predict neurodevelopmental outcomes in this
population.
The ideal surrogate outcome is inexpensive, easy to diag-
nose or observe, can be measured independent of treatment
assignment, and is free of measurement error. The clinical
outcome score that we developed does not incorporate
any laboratory investigations and is therefore not associated
with any cost. The components of the score (eg, time to
first extubation) apply to all infants undergoing CPB sur-
gery. The score is easy to calculate, and can be done before
a patient’s discharge from intensive care. Posting the deriva-
tion of the score (Table 1) in clinical settings (ie, ICU)
would allow clinicians to quickly and accurately calculate
the score for a given patient.
Our study has several limitations. Patients were operated
on at a single surgical center, and therefore the validity of
our findings should be confirmed in a multicenter study.gery c May 2013
Mackie et al Congenital Heart Disease
C
H
DFor example, timing of sternal closure varies widely among
centers. The sample size is relatively small and the ‘‘other
group’’ (n ¼ 21) represents a heterogeneous group of
lesions and surgical interventions. The timing of postoper-
ative lactates was not prespecified but rather was at the dis-
cretion of the responsible intensivist. It is possible that
patients who were more hemodynamically stable may
have had less frequent lactate monitoring and therefore
may have taken relatively longer to achieve a lactate level
2.0 mmol/L compared with patients who were deemed
more hemodynamically unstable. Nonetheless we demon-
strated a strong correlation between clinical outcome score
and time to normalization of lactate. The long-term predic-
tive ability of a PDI measured at age, 18 to 24 months is un-
clear. This is an observational study and therefore we can
only establish an association between clinical score and
PDI, not a cause-and-effect relationship. The clinical out-
come score may not distinguish moderate from severely im-
paired brain function. In the multiple regression model it
was not possible to adjust for ICU LOS, total hospital
LOS, or duration of preoperative ventilation, because these
variables are highly correlated with the clinical outcome
score. For the same reason we were not able to control for
single ventricle status in our multiple regression models.
However, a separate analysis for the biventricular group
indicated similar conclusions in terms of associations
between clinical outcome score and neurodevelopmental
outcomes (data not shown), reflecting the value of the clin-
ical outcome score within the biventricular group. A sepa-
rate analysis for the single ventricle group was not
possible due to the small sample size. The Bayley III score
has recently replaced the BSID-II, but at the time of study
initiation we had a small sample of subjects who had com-
pleted a Bayley III. The results of this study cannot be gen-
eralized to the Bayley III, and therefore a similar study of
patients who have completed a Bayley III assessment will
be required to further validate the predictive ability of the
clinical outcome score. Although the score is associated
with adverse PDI score and with important perioperative
clinical events such as time to normalization of lactate,
we have not demonstrated that interventions aimed at low-
ering the score in any class of patients are associated with
improvement in outcomes. By excluding subjects who
died before a BSID-II assessment, we may have introduced
bias in the relationship between clinical outcome score and
postoperative clinical events, but this does not affect the
demonstrated relationship between clinical outcome score
and PDI score.
CONCLUSIONS
The novel clinical outcome score we describe was asso-
ciated with adverse PDI score at age, 18 to 24 months and
correlated strongly with other markers of postoperative
events, including time to normalization of serum lactateThe Journal of Thoracic and Carand ICU and hospital LOS. This score is easy to calculate,
has no cost, and can be used to identify children who may
benefit from early and comprehensive neurodevelopmental
intervention. The score is cardiac ICU-specific, and may be
valuable as an outcome variable in future studies aimed at
evaluating novel therapies in this high risk population.References
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FIGURE E1. Relationship between postoperative intensive care unit
(ICU) length of stay and clinical outcome score (rho ¼ 0.73; P<.0001).
TABLE E1. Psychomotor Developmental Index regression
Variable
Univariate regression Multiple regression
Effect (95% CI) P value Effect size (95% CI) P value
Antenatal diagnosis 4.10 (11.24, 3.05) .258
Sex 2.04 (4.71, 8.80) .549
Birth weight (g) 0.00 (0.00, 0.01) .149
Gestational age (wk) 1.13 (1.31, 3.58) .360
Age at surgery (d) 0.39 (0.66,0.11) .006 0.40 (0.68,0.13) .005
Duration of preoperative ventilation (d) 0.87 (1.34,0.41) .000
Year of surgery 1.26 (4.44, 1.93) .435
Duration of CPB (min) 0.05 (0.11, 0.01) .093
Duration of DHCA (min) 0.10 (0.37, 0.17) .449
Lowest flow (mL/kg/min) (>10 min) 0.03 (0.06, 0.11) .557
Norwood/single ventricle 10.20 (17.17,3.23) .005
Total mother’s education 0.01 (1.62, 1.60) .990
Clinical outcome score 1 vs 0 6.02 (3.12, 15.16) .194 2.40 (13.78, 8.98) .676
Clinical outcome score 2 vs 0 6.45 (1.68, 14.58) .119 3.54 (14.36, 7.28) .517
Clinical outcome score 3 vs 0 9.69 (18.70,0.68) .035 15.44 (26.79,4.08) .008
Clinical outcome score 4 vs 0 3.51 (12.25, 5.23) .427 10.98 (22.09, 0.14) .053
Clinical outcome score 5 vs 0 0.06 (11.03, 10.91) .991 10.78 (23.86, 2.31) .105
Clinical outcome score 6 or 7 vs 0 11.35 (23.26, 0.57) .062 16.08 (29.56,2.61) .020
CI, Confidence interval; CPB, cardiopulmonary bypass; DHCA, deep hypothermic circulatory arrest.
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TABLE E2. Mental Developmental Index regression
Variable
Univariate regression Multiple regression
Effect (95% CI) P value Effect size (95% CI) P value
Antenatal diagnosis 0.60 (6.97, 8.16) .876
Sex 3.94 (3.14, 11.01) .272
Birth weight (g) 0.01 (0.00, 0.01) .058
Gestational age (wk) 2.43 (0.10, 4.97) .060
Age at surgery (d) 0.46 (0.74,0.17) .002 0.35 (0.64,0.06) .019
Duration of preoperative ventilation (d) 0.48 (0.99, 0.03) .067
Year of surgery 2.47 (0.86, 5.79) .144
Duration of CPB (min) 0.03 (0.10, 0.03) .305
Duration of DHCA (min) 0.11 (0.41, 0.19) .453
Lowest flow (mL/kg/min) (>10 min) 0.04 (0.13, 0.05) .361
Norwood/single ventricle 1.70 (9.33, 5.94) .660
Total mother’s education 2.87 (1.27, 4.46) .001 2.56 (0.96, 4.16) .002
Clinical outcome score 1 vs 0 2.53 (7.15, 12.22) .605 1.03 (12.76, 10.69) .861
Clinical outcome score 2 vs 0 4.36 (4.25, 12.98) .317 0.74 (10.43, 11.91) .896
Clinical outcome score 3 vs 0 0.30 (9.99, 9.40) .952 4.20 (15.94, 7.53) .479
Clinical outcome score 4 vs 0 3.00 (12.20, 6.20) .520 7.09 (18.56, 4.38) .223
Clinical outcome score 5 vs 0 5.88 (5.60, 17.35) .312 0.27 (13.23, 13.78) .968
Clinical outcome score 6 or 7 vs 0 16.15 (28.48,3.81) .011 13.25 (27.21, 0.72) .063
CI, Confidence interval; CPB, cardiopulmonary bypass; DHCA, deep hypothermic circulatory arrest.
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